GlaxoSmithKline Pakistan (KAR:GLAXO) Other Stockholders Equity : ₨5,127 Mil (As of Sep. 2024)

View and export this data going back to 1953. Start your Free Trial

What is GlaxoSmithKline Pakistan Other Stockholders Equity?

GlaxoSmithKline Pakistan's Other Stockholders Equity for the quarter that ended in Sep. 2024 was ₨5,127 Mil.

GlaxoSmithKline Pakistan's quarterly Other Stockholders Equity increased from Mar. 2024 (₨5,127 Mil) to Jun. 2024 (₨5,127 Mil) but then declined from Jun. 2024 (₨5,127 Mil) to Sep. 2024 (₨5,127 Mil).

GlaxoSmithKline Pakistan's annual Other Stockholders Equity stayed the same from Dec. 2021 (₨5,127 Mil) to Dec. 2022 (₨5,127 Mil) and stayed the same from Dec. 2022 (₨5,127 Mil) to Dec. 2023 (₨5,127 Mil).

GlaxoSmithKline Pakistan Other Stockholders Equity Historical Data

The historical data trend for GlaxoSmithKline Pakistan's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pakistan Other Stockholders Equity Chart

GlaxoSmithKline Pakistan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

5,126.89

GlaxoSmithKline Pakistan Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															5,126.89	5,126.89	5,126.89	5,126.89	5,126.89

GlaxoSmithKline Pakistan Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

GlaxoSmithKline Pakistan Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pakistan's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Pakistan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pakistan Ltd (KAR:GLAXO) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

35, Dockyard Road, West Wharf, Karachi, PAK, 74000

Website

https://www.pk.gsk.com

GlaxoSmithKline Pakistan Ltd is engaged in research, development, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. It is involved in Anti-infective, Respiratory, Vaccines, Dermatological, Gastrointestinal, Analgesics, Urology, Central Nervous System, Allergy, Cardiovascular and Vitamins therapy areas. The operating business divisions are Pharmaceuticals and Consumer Healthcare. The pharmaceutical brands of the company include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and prominent vaccines include Synflorix, Infanrix Hexa, Rotarix, Engerix-B, Havrix, and Cervarix. The company derives maximum revenue from Pharmaceuticals segment.

GlaxoSmithKline Pakistan Headlines

No Headlines